05-Jun-2008 - Chimera Biotec GmbH

Chimera Biotec invites scientists to the III. Immunolympics 2008

For the third time Chimera Biotec supports the scientific community with a contest on ultra-sensitive immunoassays, the III. Immunolympics are open. The contest seeks to find potential solutions to today's scientific challenges using ultra-sensitive immunoassays.

It's the third time that Germany-based Chimera Biotec inspires the scientific community with a contest on ultra-sensitive immunoassays. The contest seeks to find solutions to today's scientific challenges using ultra-sensitive immunoassays.

Ultra-sensitive Biomarker quantification based on immunoassays has become an essential tool in drug development, as well as in various research areas (CNS, cancer, inflammation, vaccines, etc.). It has been estimated that 80-90% of all the proteome cannot be quantified using conventional ELISA technologies. The Immunolympics aims to inspire the scientific community on their hunt for relevant biomarkers, proteins and peptides deep down in the proteome.

Facts, background information, dossiers
More about Chimera Biotec